BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Oct. 23, 2014
View Archived Issues
Inside the Beltway:FDA custom device final guidance allows five devices per indication
Read More
Beta-O2 treats first patient in Bio-Artificial pancreas trial
Read More
Daily M&A: OxySure Systems and Estill to merge, financial details not disclosed
Read More
Financings: Nanosphere's 40M share offering could raise more than $21 million
Read More
World in Review: Foundation Medicine, WuXi, to offer profiling to biopharma in China
Read More
Grants:Antigen Discovery gains SBIR from NIH to develop HIV Microarray chip
Read More
Agreeements/contracts
Read More
Briefly Noted
Read More
Products
Read More
MDD's Orthopedics Extra
Read More
United European Gastroenterology Meeting: Robotic colonoscopy said to eliminate pain, reduces costs
VIENNA — Discomfort is the leading reason people give for not undergoing a colonoscopy, and the leading cause of non-compliance with this gold standard for colorectal cancer screening.
Read More
Reimbursement Review:Rising middle class offset by price pressure in India med-tech market
Read More
